...
首页> 外文期刊>Birdem Medical Journal >Follow-up and treatment pattern during Ramadan and evaluation of the outcome of Ramadan fasting on clinical, biochemical and metabolic parameters in patients with type 2 diabetes mellitus: a realworld, multi-center, prospective observational study
【24h】

Follow-up and treatment pattern during Ramadan and evaluation of the outcome of Ramadan fasting on clinical, biochemical and metabolic parameters in patients with type 2 diabetes mellitus: a realworld, multi-center, prospective observational study

机译:斋月期间的随访和治疗模式和斋月禁食ramadan患者临床,生化和代谢参数的评估,患有2型糖尿病患者:Realworld,多中心,前瞻性观察研究

获取原文
           

摘要

Background: There are variable effects of Ramadan fasting on clinical and biochemical variables of diabetic people. Anti-diabetic agents are often adjusted during this time to reflect changes in lifestyle. The study was conducted to understand the diversity of follow-up, treatment pattern, clinical, and biochemical outcome of Ramadan fasting among type 2 diabetic patients who observed Ramadan fast.Methods: This real-world, multi-center, prospective, observational study was conducted at the diabetes outpatient department of National Healthcare Network (NHN) Uttara Center of Bangladesh Diabetic Somity (BADAS), Dhaka, Bangladesh and outpatient department of MARKS Hormone and Diabetes clinic, MARKS Medical College amp;Hospital in Dhaka, Bangladesh upon randomly selected type 2 diabetic patients, recruited 1 to 12 weeks prior to the Ramadan and followed up till 12 weeks post-Ramadan period. Finally, a total of 271 participants completed satisfactory follow up. Data was collected before, during, and after Ramadan using a set of questionnaires in a face to face interview.Results: The majority (80.1%) of participants received pre-Ramadan education, counseling, adjustment of medication and other direction to help them cope with Ramadan fasting. A significant reduction of weight, body mass index (BMI)) and blood pressure were reported after Ramadan fast (p0.001). None of the studied participants experienced severe hyper/hypoglycemia or acute complications requiring hospitalization or an emergency room visit. Metformin was the commonest prescribed anti-diabetic medication. Premixed insulin was the commonest insulin regimen during study period. Three most commonly adjusted oral anti-diabetic drugs were gliclazide, glimepiride, metformin and insulin doses were also adjusted. Mean of fasting and prandial capillary blood glucose decreased from pre-Ramadan period to post-Ramadan period (P0.05). HbA1c decreased during post-Ramadan period compared to pre-Ramadan visit (P=0.13). A significant reduction in the triglyceride level was observed during post-Ramadan follow up (P 0.05).Conclusion: The study revealed that a safe fasting can be observed with proper pre-Ramadan work-up. Ramadan fasting resulted into significant reduction of weight, BMI, blood pressure, lipid profile and improved glycemic status in patients with type 2 diabetes.Birdem Med J 2021; 11(1): 30-38.
机译:背景:斋月禁食糖尿病患者的临床和生化变量存在可变影响。在此期间通常调整抗糖尿病药剂以反映生活方式的变化。该研究是为了了解斋月患者中斋月禁食的随访,治疗模式,临床和生化结果的多样性。方法:这个现实世界,多中心,前瞻性的观察研究在孟加拉国糖尿病糖尿病患者(BADAS),达卡,孟加拉国和门诊部诊所,德国达巴达诊所的糖尿病患者,达卡,Marks Medical College,Marks Medical College;孟加拉国,孟加拉国在随机选择的类型2名糖尿病患者,在斋月前招募1至12周,然后后续到斋月期后12周。最后,共有271名参与者完成了令人满意的跟进。在ramadan之前,使用一组问卷在面对面试的情况下收集数据。结果:参与者的大多数(80.1%)接受了斋月教育,咨询,调整药物和其他方向,以帮助他们应对斋月禁食。在Ramadan Fast(PLT; 0.001)之后报告重量,体重指数(BMI))和血压的显着降低。学习的参与者都没有经历过治疗或急诊室访问的严重的高钙/低血糖或急性并发症。二甲双胍是最常见的规定的抗糖尿病药物。预混合的胰岛素是研究期间最常见的胰岛素方案。三种最常见的口服抗糖尿病药物是Gliclazide,Glimepiride,二甲双胍和胰岛素剂量也调节。禁食和折叠毛细血管血糖的平均值从斋月期到斋月期(PLT; 0.05)下降。与斋月度前,HBA1C在后斋月期间减少(P = 0.13)。在斋月后,观察到甘油三酯水平的显着降低(PLT; 0.05)。结论:该研究表明,可以使用适当的ramadan处理来观察安全禁食。斋月禁食导致重量,BMI,血压,脂质型材和2型糖尿病患者的提高血糖状态的显着降低.Birdem Med J 2021; 11(1):30-38。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号